Alzecure Pharma Ab Stock Filter Stocks by Fundamentals
AC6 Stock | EUR 0.30 0.02 7.14% |
Fundamental analysis of ALZECURE PHARMA allows traders to better anticipate movements in ALZECURE PHARMA's stock price by examining its financial health and performance throughout various phases of its business cycle.
ALZECURE |
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
ALZECURE Fundamentals
Return On Equity | -1.55 | |||
Return On Asset | -0.78 | |||
Shares Outstanding | 59.19 M | |||
Shares Owned By Insiders | 34.06 % | |||
Shares Owned By Institutions | 5.56 % | |||
Price To Earning | (183.73) X | |||
EBITDA | 2.58 M | |||
Net Income | (7.21 M) | |||
Cash And Equivalents | 18.67 M | |||
Cash Per Share | 0.06 X | |||
Total Debt | 723.85 K | |||
Debt To Equity | 0.80 % | |||
Current Ratio | 48.72 X | |||
Book Value Per Share | 0.28 X | |||
Cash Flow From Operations | 356.17 K | |||
Number Of Employees | 14 | |||
Beta | 0.74 | |||
Market Capitalization | 24.47 M | |||
Z Score | 19.8 |
About ALZECURE PHARMA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ALZECURE PHARMA AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ALZECURE PHARMA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ALZECURE PHARMA AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ALZECURE Stock
ALZECURE PHARMA financial ratios help investors to determine whether ALZECURE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALZECURE with respect to the benefits of owning ALZECURE PHARMA security.